Antisocial personality disorder, psychopathy and injecting heroin use.
Two hundred community-based methadone patients (CM); 200 prison inmates enrolled in prison methadone programs (PM); and 150 prison inmates with no history of heroin use (PNH) were interviewed to obtain diagnoses of antisocial personality disorder (ASPD) and Psychopathy Checklist-defined psychopathy. Large proportions of subjects in all three groups met the criteria for a diagnosis of ASPD (CM 44%, PM 65%, PNH 31%), with the two methadone groups having significantly higher proportions of ASPD diagnoses than non-heroin users. There were no differences between groups in the proportions diagnosed as psychopathic (CM 4%, PM 9%, PNH 4%). For each group, the proportions diagnosed as ASPD were significantly higher than the proportions diagnosed as psychopathic. Implications for the diagnosis of ASPD are discussed.
Darke
S
S
National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Kaye
S
S
Finlay-Jones
R
R
D000293:Adolescent; D000328:Adult; D000987:Antisocial Personality Disorder / Q000150:complications* / Q000175:diagnosis / Q000523:psychology*; D005260:Female; D006556:Heroin Dependence / Q000150:complications* / Q000175:diagnosis / Q000534:rehabilitation; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D008875:Middle Aged; D009294:Narcotics / Q000627:therapeutic use; D011329:Prisoners / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D015819:Substance Abuse, Intravenous
D009294:Narcotics; D008691:Methadone